Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$352K Sell
1,602
-263
-14% -$62.5K 0.1% 64
2026
Q2
$524K Buy
1,865
+34
+2% +$8.57K 0.15% 51
2026
Q1
$445K Sell
1,831
-6
-0.3% -$1.62K 0.16% 51
2025
Q4
$544K Sell
1,837
-38
-2% -$11.4K 0.19% 46
2025
Q3
$529K Buy
1,875
+14
+0.8% +$3.66K 0.19% 46
2025
Q2
$549K Buy
1,861
+29
+2% +$7.47K 0.22% 43
2025
Q1
$456K Buy
1,832
+90
+5% +$22K 0.2% 44
2024
Q4
$383K Sell
1,742
-32
-2% -$7.13K 0.18% 56
2024
Q3
$392K Buy
1,774
+22
+1% +$4.31K 0.19% 55
2024
Q2
$303K Buy
1,752
+249
+17% +$43.3K 0.16% 64
2024
Q1
$287K Buy
1,503
+476
+46% +$86.8K 0.15% 66
2023
Q4
$168K Sell
1,027
-40
-4% -$6.04K 0.12% 76
2023
Q3
$150K Buy
1,067
+15
+1% +$2.13K 0.12% 74
2023
Q2
$141K Sell
1,052
-129
-11% -$16.6K 0.11% 83
2023
Q1
$155K Sell
1,181
-14
-1% -$1.87K 0.12% 78
2022
Q4
$168K Buy
1,195
+1
+0.1% +$138 0.14% 71
2022
Q3
$142K Buy
1,194
+406
+52% +$53.3K 0.12% 74
2022
Q2
$111K Sell
788
-50
-6% -$6.75K 0.11% 86
2022
Q1
$109K Sell
838
-12
-1% -$1.56K 0.1% 93
2021
Q4
$114K Buy
+850
New +$107K 0.11% 91

Other funds holding IBM

Rise Advisors's IBM Position: Q3 2026 in Review

Rise Advisors reduced its IBM (IBM) stake by 14% in Q3 2026, selling an estimated $62.5K and leaving 1,602 shares worth $352K. The position accounts for 0.1% of the portfolio, ranked #64.

Rise Advisors first reported a position in IBM in Q4 2021 and has held it in 20 quarters since. The position peaked at $549K in Q2 2025. 1,204 funds tracked by Wall St. Rank hold IBM as of Q3 2026.

  • Rise Advisors held 1,602 shares of IBM worth $352K as of Q3 2026.
  • Rise Advisors sold 263 IBM shares in Q3 2026, an estimated $62.5K.
  • IBM made up 0.1% of Rise Advisors's portfolio in Q3 2026, its #64 holding.
  • Rise Advisors first reported a position in IBM in Q4 2021 and has held it in 20 quarters since.
  • Rise Advisors's IBM position peaked at $549K in Q2 2025.
  • 1,204 funds tracked by Wall St. Rank held IBM as of Q3 2026.

Based on Rise Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.